Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia
Primary Purpose
Familial Hypercholesterolemia
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dietary intervention
Sponsored by
About this trial
This is an interventional treatment trial for Familial Hypercholesterolemia focused on measuring Diet study
Eligibility Criteria
Inclusion Criteria:
- Adults, age > 18 years or < 80 years
- Pre-treatment LDL-C greater than the 95th percentile for age and sex (corresponding to 190 mg/dL for most adults), with one of the 2 following criteria: (1) tendon xanthoma (proband or first-degree relative) or (2) either first-degree relative with premature CHD (age less than 55 years in men or 65 years in women) or pretreatment LDL-C greater than the 95th percentile for age and sex.
- Willing to come off medical therapy 4 weeks before and during study.
- Willing to follow high/low saturated fat diet
- Willing to attend dietary counseling sessions
- Willing to attend frequent clinic visits
- Subjects willing to participate under the conditions described in the informed consent form (ICF) and able to sign the ICF and applicable HIPAA forms.
Exclusion Criteria:
- Presence of any clinically significant uncontrolled endocrine disease known to influence serum lipids or lipoproteins. Note: patients on thyroid replacement therapy can be included if the dosage of thyroxine has been stable for 6 weeks prior to the first study visit and thyroid-stimulating hormone (TSH) level is within the normal range.
- Conditions of severe acute vascular stress (e.g. acute coronary syndrome, ischemic stroke, or major vascular surgery) within 3 months prior to the first study visit.
- Patients unable to maintain their current activity level or planning to increase their activity level (e.g. new exercise regimen).
- Pregnant or breast-feeding women.
- Major illness
- Secondary cause of dyslipidemia (e.g. obstructive liver disease, hypothyroidism, or nephrotic syndrome)
- Hospitalization within 3 months
- Substance abuse (illegal drug use, chronic alcoholism or problematic use of alcohol or total daily alcohol intake >2 drinks per day in men and > 1 drink per day in women).
- Immunodeficiency or HIV-positive status
- Illiteracy
- Severe medical condition that may impair the ability of the person to participate in a nutrition intervention study (e.g. digestive disease with fat intolerance, advanced malignancy, or major neurological, psychiatric or endocrine disease)
- Any other medical condition thought to limit survival to less than 1 year
- Difficulties or major inconvenience to change dietary habits
- History of food allergy with hypersensitivity to any of the components of olive oil or nuts
Sites / Locations
- UT Southwestern Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Low Saturated Fat Diet
High Saturated Fat Diet
Arm Description
Goal will be to attain <7% of daily calories from saturated fat. Replace it with energy from monounsaturated fat.
Goal will be to attain 15% of daily calories from saturated fat. Decrease intake of monounsaturated fat.
Outcomes
Primary Outcome Measures
Change in LDL-cholesterol
To quantify the change in low density lipoprotein cholesterol
Secondary Outcome Measures
Full Information
NCT ID
NCT03756779
First Posted
July 28, 2017
Last Updated
November 26, 2018
Sponsor
University of Texas Southwestern Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03756779
Brief Title
Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia
Official Title
Randomized, Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Not enrolling subjects in the study.
Study Start Date
May 15, 2017 (Actual)
Primary Completion Date
June 30, 2020 (Anticipated)
Study Completion Date
June 30, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Texas Southwestern Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
We are performing a pilot cross-over diet study involving 5 patients with heterozygous FH and 5 patients with unexplained ADH. The patients will be randomized to a low versus high saturated fat diet for 4 weeks each. We hypothesize that patients with unexplained ADH may have an exaggerated cholesterol response to saturated fat intake. The specific aim of this study is to quantify the increase in LDL-C in unexplained ADH patients compared to FH patients. The pilot study proposed here will develop preliminary data to be used for future funding proposals of larger, randomized studies.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Familial Hypercholesterolemia
Keywords
Diet study
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low Saturated Fat Diet
Arm Type
Experimental
Arm Description
Goal will be to attain <7% of daily calories from saturated fat. Replace it with energy from monounsaturated fat.
Arm Title
High Saturated Fat Diet
Arm Type
Active Comparator
Arm Description
Goal will be to attain 15% of daily calories from saturated fat. Decrease intake of monounsaturated fat.
Intervention Type
Other
Intervention Name(s)
Dietary intervention
Intervention Description
Dietary intervention with dietary modification of fat intake.
Primary Outcome Measure Information:
Title
Change in LDL-cholesterol
Description
To quantify the change in low density lipoprotein cholesterol
Time Frame
4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults, age > 18 years or < 80 years
Pre-treatment LDL-C greater than the 95th percentile for age and sex (corresponding to 190 mg/dL for most adults), with one of the 2 following criteria: (1) tendon xanthoma (proband or first-degree relative) or (2) either first-degree relative with premature CHD (age less than 55 years in men or 65 years in women) or pretreatment LDL-C greater than the 95th percentile for age and sex.
Willing to come off medical therapy 4 weeks before and during study.
Willing to follow high/low saturated fat diet
Willing to attend dietary counseling sessions
Willing to attend frequent clinic visits
Subjects willing to participate under the conditions described in the informed consent form (ICF) and able to sign the ICF and applicable HIPAA forms.
Exclusion Criteria:
Presence of any clinically significant uncontrolled endocrine disease known to influence serum lipids or lipoproteins. Note: patients on thyroid replacement therapy can be included if the dosage of thyroxine has been stable for 6 weeks prior to the first study visit and thyroid-stimulating hormone (TSH) level is within the normal range.
Conditions of severe acute vascular stress (e.g. acute coronary syndrome, ischemic stroke, or major vascular surgery) within 3 months prior to the first study visit.
Patients unable to maintain their current activity level or planning to increase their activity level (e.g. new exercise regimen).
Pregnant or breast-feeding women.
Major illness
Secondary cause of dyslipidemia (e.g. obstructive liver disease, hypothyroidism, or nephrotic syndrome)
Hospitalization within 3 months
Substance abuse (illegal drug use, chronic alcoholism or problematic use of alcohol or total daily alcohol intake >2 drinks per day in men and > 1 drink per day in women).
Immunodeficiency or HIV-positive status
Illiteracy
Severe medical condition that may impair the ability of the person to participate in a nutrition intervention study (e.g. digestive disease with fat intolerance, advanced malignancy, or major neurological, psychiatric or endocrine disease)
Any other medical condition thought to limit survival to less than 1 year
Difficulties or major inconvenience to change dietary habits
History of food allergy with hypersensitivity to any of the components of olive oil or nuts
Facility Information:
Facility Name
UT Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia
We'll reach out to this number within 24 hrs